arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2405.00577cs.LGeess.SPq-bio.NC

通过图神经网络从静息态功能性磁共振成像中发现心理障碍的稳健生物标志物:系统综述

Discovering robust biomarkers of psychiatric disorders from resting-state functional MRI via graph neural networks: A systematic review

College of Computing and Data Science, Nanyang Technological University(南洋理工大学计算与数据科学学院);Department of Computer Science and Engineering, Indian Institute of Technology(印度理工学院计算机科学与工程系)

Yi Hao Chan, Deepank Girish, Sukrit Gupta, Jing Xia, Chockalingam Kasi, Yinan He, Conghao Wang, Jagath C. Rajapakse

AI总结:

本文综述了利用图神经网络和模型可解释性技术在静息态fMRI数据中发现心理障碍生物标志物的研究,指出现有方法在评估生物标志物稳健性时存在主观性,提出建立客观评估标准以提高可重复性。

摘要:

图神经网络(GNN)已逐渐成为建模功能性磁共振成像(fMRI)数据集的流行工具。许多最近的研究报告了通过更复杂的GNN设计显著提高了疾病分类性能,并突显了可能成为疾病生物标志物的显著特征。然而,现有方法在评估其稳健性时往往局限于与现有文献的交叉参考,这是一个主观且不一致的过程。在本文综述中,我们概述了GNN和模型可解释性技术(特别是特征归因器)如何应用于fMRI数据集进行疾病预测任务,重点在于评估为心理障碍产生的潜在生物标志物的稳健性。然后,从两个在线数据库(Scopus,PubMed)中识别出65项使用GNN并报告了心理障碍(注意力缺陷多动障碍,自闭症谱系障碍,重度抑郁障碍,精神分裂症)的潜在fMRI生物标志物的研究,这些研究发表于2024年10月9日之前。我们发现,尽管大多数研究具有高性能模型,但这些研究中突出的特征(根据特征归因分数确定)在相同疾病的研究中差异很大。生物标志物的可重复性仅限于区域层面的小子集,且仅识别出少量跨诊断生物标志物。为了解决这些问题,我们建议建立基于客观评估指标的新标准,以确定这些潜在生物标志物的稳健性。我们进一步强调现有文献中的差距,并提出一个预测-归因-评估框架,这可以为通过GNN发现心理障碍稳健生物标志物的未来研究奠定基础。

英文摘要:

Graph neural networks (GNN) have emerged as a popular tool for modelling functional magnetic resonance imaging (fMRI) datasets. Many recent studies have reported significant improvements in disorder classification performance via more sophisticated GNN designs and highlighted salient features that could be potential biomarkers of the disorder. However, existing methods of evaluating their robustness are often limited to cross-referencing with existing literature, which is a subjective and inconsistent process. In this review, we provide an overview of how GNN and model explainability techniques (specifically, feature attributors) have been applied to fMRI datasets for disorder prediction tasks, with an emphasis on evaluating the robustness of potential biomarkers produced for psychiatric disorders. Then, 65 studies using GNNs that reported potential fMRI biomarkers for psychiatric disorders (attention-deficit hyperactivity disorder, autism spectrum disorder, major depressive disorder, schizophrenia) published before 9 October 2024 were identified from 2 online databases (Scopus, PubMed). We found that while most studies have performant models, salient features highlighted in these studies (as determined by feature attribution scores) vary greatly across studies on the same disorder. Reproducibility of biomarkers is only limited to a small subset at the level of regions and few transdiagnostic biomarkers were identified. To address these issues, we suggest establishing new standards that are based on objective evaluation metrics to determine the robustness of these potential biomarkers. We further highlight gaps in the existing literature and put together a prediction-attribution-evaluation framework that could set the foundations for future research on discovering robust biomarkers of psychiatric disorders via GNNs.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑